Michael Resl

1.3k total citations
53 papers, 885 citations indexed

About

Michael Resl is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Michael Resl has authored 53 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Cardiology and Cardiovascular Medicine and 10 papers in Surgery. Recurrent topics in Michael Resl's work include Diabetes Treatment and Management (18 papers), Heart Failure Treatment and Management (14 papers) and Cardiovascular Function and Risk Factors (10 papers). Michael Resl is often cited by papers focused on Diabetes Treatment and Management (18 papers), Heart Failure Treatment and Management (14 papers) and Cardiovascular Function and Risk Factors (10 papers). Michael Resl collaborates with scholars based in Austria, Germany and Australia. Michael Resl's co-authors include Martin Clodi, Anton Luger, Greisa Vila, Richard Pacher, Stephanie Neuhold, Guido Strunk, Rudolf Prager, Michaela Riedl, Christopher Adlbrecht and Martin Hülsmann and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Diabetes Care.

In The Last Decade

Michael Resl

49 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Resl Austria 15 462 219 212 209 108 53 885
Petra Kaválková Czechia 21 220 0.5× 158 0.7× 155 0.7× 410 2.0× 135 1.3× 55 1.3k
Ursula Hanusch‐Enserer Austria 15 159 0.3× 171 0.8× 94 0.4× 350 1.7× 67 0.6× 20 801
Christoph Birner Germany 18 524 1.1× 59 0.3× 50 0.2× 167 0.8× 49 0.5× 57 890
Joel Estis United States 17 323 0.7× 66 0.3× 64 0.3× 106 0.5× 52 0.5× 39 696
Mirosława Urban Poland 14 191 0.4× 209 1.0× 45 0.2× 95 0.5× 147 1.4× 74 796
Hans‐Dirk Düngen Germany 14 301 0.7× 85 0.4× 30 0.1× 89 0.4× 41 0.4× 22 546
Satoki Homma Japan 14 299 0.6× 151 0.7× 30 0.1× 128 0.6× 74 0.7× 33 773
Matthias Lenski Germany 13 1.1k 2.5× 187 0.9× 53 0.3× 54 0.3× 58 0.5× 14 1.4k
BR Walker United Kingdom 13 108 0.2× 597 2.7× 97 0.5× 191 0.9× 50 0.5× 25 1.1k
Hüsniye Yüksel Türkiye 15 190 0.4× 198 0.9× 21 0.1× 178 0.9× 69 0.6× 37 776

Countries citing papers authored by Michael Resl

Since Specialization
Citations

This map shows the geographic impact of Michael Resl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Resl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Resl more than expected).

Fields of papers citing papers by Michael Resl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Resl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Resl. The network helps show where Michael Resl may publish in the future.

Co-authorship network of co-authors of Michael Resl

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Resl. A scholar is included among the top collaborators of Michael Resl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Resl. Michael Resl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clodi, Martin, Michael Resl, Heidemarie Abrahamian, Bernhard Föger, & Raimund Weitgasser. (2023). Therapie der Hyperglykämie bei erwachsenen, kritisch kranken PatientInnen (Update 2023). Wiener klinische Wochenschrift. 135(S1). 272–274.
2.
Resl, Michael. (2023). Leitlinien Österreichische Diabetesgesellschaft. Wiener klinische Wochenschrift. 135(S1). 1–6. 4 indexed citations
3.
Kaser, Susanne, Sabine E. Hofer, Lili Kazemi-Shirazi, et al.. (2023). Andere spezifische Diabetesformen und exokrine Pankreasinsuffizienz (Update 2023). Wiener klinische Wochenschrift. 135(S1). 18–31.
4.
Resl, Michael, et al.. (2022). Effect of repeated bolus and continuous glucose infusion on a panel of circulating biomarkers in healthy volunteers. PLoS ONE. 17(12). e0279308–e0279308. 3 indexed citations
5.
Resl, Michael, Anne Black, Thomas Wagner, et al.. (2022). High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with COVID-19 Vaccine Breakthrough Infection. International Journal of Environmental Research and Public Health. 19(23). 15581–15581. 4 indexed citations
6.
Resl, Michael, Greisa Vila, A Luger, et al.. (2021). Changes in the prognostic values of modern cardiovascular biomarkers in relation to duration of diabetes mellitus. Journal of Diabetes and its Complications. 35(9). 107990–107990. 7 indexed citations
7.
Prausmüller, Suriya, Michael Resl, Henrike Arfsten, et al.. (2021). Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus. Cardiovascular Diabetology. 20(1). 34–34. 26 indexed citations
8.
9.
Resl, Michael, et al.. (2019). Intrahospital mortality of influenza patients during the 2017–2018 influenza season. Wiener klinische Wochenschrift. 132(7-8). 176–181. 5 indexed citations
10.
Clodi, Martin, Michael Resl, Heidemarie Abrahamian, Bernhard Föger, & Raimund Weitgasser. (2019). Therapie der Hyperglykämie bei erwachsenen, kritisch kranken PatientInnen (Update 2019). Wiener klinische Wochenschrift. 131(S1). 218–220. 3 indexed citations
11.
Kaser, Susanne, Yvonne Winhofer-Stöckl, Lili Kazemi-Shirazi, et al.. (2019). Andere spezifische Diabetesformen und exokrine Pankreasinsuffizienz (Update 2019). Wiener klinische Wochenschrift. 131(S1). 16–26. 5 indexed citations
12.
Resl, Michael, Martin Clodi, Greisa Vila, et al.. (2016). Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes. Heart. 102(24). 1963–1968. 32 indexed citations
13.
Resl, Michael, Greisa Vila, Richard Pacher, et al.. (2013). Estimated glomerular filtration rate and albuminuria: true predictors of cardiovascular events in obese patients with type 2 diabetes?. Wiener klinische Wochenschrift. 125(19-20). 629–633. 4 indexed citations
14.
Vila, Greisa, Michael Resl, Birgit Heinisch, et al.. (2012). B-Type Natriuretic Peptide Modulates Ghrelin, Hunger, and Satiety in Healthy Men. Diabetes. 61(10). 2592–2596. 49 indexed citations
15.
Resl, Michael, Martin Clodi, Stephanie Neuhold, et al.. (2011). Serum uric acid is related to cardiovascular events and correlates with N‐terminal pro‐B‐type natriuretic peptide and albuminuria in patients with diabetes mellitus. Diabetic Medicine. 29(6). 721–725. 21 indexed citations
16.
Neuhold, Stephanie, Michael Resl, M Huelsmann, et al.. (2011). Repeat measurements of glycated haemoglobin A1c and N‐terminal pro‐B‐type natriuretic peptide: divergent behaviour in diabetes mellitus. European Journal of Clinical Investigation. 41(12). 1292–1298. 17 indexed citations
17.
Heinisch, Birgit, Greisa Vila, Michael Resl, et al.. (2011). B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men. Diabetologia. 55(5). 1400–1405. 39 indexed citations
18.
Resl, Michael, Martin Hülsmann, Richard Pacher, & Martin Clodi. (2009). Diabetische Herzinsuffizienz. Wiener Medizinische Wochenschrift. 159(5-6). 134–140. 2 indexed citations
19.
Vila, Greisa, Michaela Riedl, Michael Resl, et al.. (2009). Systemic administration of oxytocin reduces basal and lipopolysaccharide-induced ghrelin levels in healthy men. Journal of Endocrinology. 203(1). 175–179. 25 indexed citations
20.
Vila, Greisa, Michael Resl, David Stelzeneder, et al.. (2008). Plasma NT-proBNP increases in response to LPS administration in healthy men. Journal of Applied Physiology. 105(6). 1741–1745. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra Kaválková Breakdown of academic impact, for papers by Ursula Hanusch‐Enserer Breakdown of academic impact, for papers by Christoph Birner Breakdown of academic impact, for papers by Joel Estis Breakdown of academic impact, for papers by Mirosława Urban Breakdown of academic impact, for papers by Hans‐Dirk Düngen Breakdown of academic impact, for papers by Satoki Homma Breakdown of academic impact, for papers by Matthias Lenski Breakdown of academic impact, for papers by BR Walker Breakdown of academic impact, for papers by Hüsniye Yüksel
Rankless by CCL
2026